Päivi Lehtonen starting as Injeq’s new Sales Director in April

The current CEO of Teivo, Päivi Lehtonen, will start as Injeq’s new Sales Director in the beginning of April. Päivi Lehtonen has Master’s degree in Business Administration and she has earlier worked, e.g. as a sales director at Orion Pharma Veterinary Medicines and as CEO of the pharmaceutical company Vetcare Oy and the veterinary clinic chain Univet. All these previous positions have included international sales and growth and so, Lehtonen will now take responsibility for scaling Injeq’s international business. Recruiting an international sales professional complements Injeq’s strategy of growing its medical business in key markets.

We wish Päivi warmly welcome to Injeq team.

Injeq webinar today, Thursday Feb 22nd, 2024

Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone)   Lecturers […]
Read more »

INJEQ IQ-Tip Webinar February 22nd, 2024

Join the webinar revealing the revolutionary technique of lumbar punctures for healthcare professionals. Discover the innovative technology behind Injeq IQ-Tip®, […]
Read more »

HKTDC London office is proud of INJEQ’s achievements

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong […]
Read more »

EGM March 1, 2024

NOTICE OF THE EXTRAORDINARY GENERAL MEETING KUTSU YLIMÄÄRÄISEEN YHTIÖKOKOUKSEEN Notice is given to the shareholders of Injeq Oyj of the […]
Read more »

Arab Health 2024 started – Injeq meets with customers

Arab Health 2024, the intersection of cutting-edge technologies, revolutionary concepts, and healthcare experts, is reshaping the healthcare landscape. Injeq CEO […]
Read more »

Season greetings!

Injeq kiittää kaikkia asiakkaitaan ja sidosryhmiään yhteistyöstä vuonna 2023 ja toivottaa rauhallista joulun aikaa! Onnea ja iloa uuteen vuoteen 2024! […]
Read more »